TP53 and neoplasm: In addition, TP53 mutations were associated with a higher tumor mutation burden (TMB), with a trend toward increased mean TMB in TP53‐mutant cases compared to TP53 wild‐type cases (4.93 ± 2.32 vs. 4.28 ± 2.10, p = 0.066) (Figure S1).